Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

NMN and Rapamycin Interaction: Compatible | Peptide Database

Compound Profiles NMN NAD+ Precursor | Cellular Energy & Longevity NMN is converted to NAD+ via the NAD+ salvage pathway. After oral ingestion, NMN is absorbed in the gut, where it may be partially converted to nicotinamide riboside (NR) by the enzyme CD73 for

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

NMN

NAD+ Precursor | Cellular Energy & Longevity

NMN is converted to NAD+ via the NAD+ salvage pathway. After oral ingestion, NMN is absorbed in the gut, where it may be partially converted to nicotinamide riboside (NR) by the enzyme CD73 for cellular uptake, then re-phosphorylated intracellularly back to NMN.

Rapamycin

mTOR Inhibitor | Longevity & Immunosuppression

Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take NMN with Rapamycin?

Yes, NMN and Rapamycin can generally be taken together. Rapamycin (mTOR inhibitor) and NMN (NAD+ precursor) target distinct but complementary aging pathways. Rapamycin modulates mTOR-driven growth signaling while NMN supports NAD+-dependent repair and energy metabolism. No known negative interactions. Some longevity researchers use both as part of comprehensive anti-aging protocols.

Is NMN and Rapamycin safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between NMN and Rapamycin?

Rapamycin (mTOR inhibitor) and NMN (NAD+ precursor) target distinct but complementary aging pathways. Rapamycin modulates mTOR-driven growth signaling while NMN supports NAD+-dependent repair and energy metabolism. No known negative interactions. Some longevity researchers use both as part of comprehensive anti-aging protocols. This assessment has 90% confidence and is based on documented research data.

How should I time NMN and Rapamycin?

NMN has a half-life of ~2-3 hours (oral) and Rapamycin has a half-life of ~62 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Research explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation. May support overall urinary tract function and tissue health. Potential benefits for pelvic tissue health and function. Research indicates potential to enhance blood flow and reduce dysfunction in prostate tissue. May help alleviate symptoms associated with benign prostatic hyperplasia. Part of comprehensive bioregulator protocols addressing age-related urogenital changes. Supports cellular regeneration in urinary and reproductive tissues.

Source: peptide-db.com ↗

Research Indications

Winlevi (clascoterone cream 1%) is FDA-approved for the topical treatment of acne vulgaris in patients 12 years and older. Phase 3 trials demonstrated statistically significant reductions in inflammatory and non-inflammatory lesion counts compared to vehicle, with an Investigator Global Assessment success rate significantly higher than placebo. Particularly relevant for women with androgen-driven acne who cannot tolerate or prefer to avoid systemic anti-androgens like spironolactone. Provides targeted anti-androgen activity at the sebaceous gland without the systemic effects, menstrual irregularities, or contraindication in pregnancy associated with oral anti-androgens. Breezula (clascoterone solution 7.5%) has completed Phase 3 clinical trials for androgenetic alopecia in men. Trial results showed improvements in target area hair count compared to vehicle. Regulatory submission is pending. The topical anti-androgen approach offers a potential alternative to systemic 5-alpha reductase inhibitors for men concerned about systemic side effects. The favorable safety profile and lack of systemic anti-androgenic effects make clascoterone a candidate for female androgenetic alopecia, where systemic anti-androgens carry teratogenic risks. Clinical data in women for this indication is still being developed.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Proviron is administered exclusively as an oral tablet, typically available in 25 mg tablets. Unlike most oral anabolic steroids, Proviron is not 17-alpha alkylated and instead relies on its 1-methyl DHT structure for oral bioavailability. This makes it one of the safest oral androgens with respect to liver toxicity. The 12-hour half-life supports once or twice daily dosing for stable blood levels. Low Dose - Libido and Mood Support 25 mg/day Once daily Oral Standard - TRT Adjunct 50 mg/day 25 mg twice daily (morning and evening) Higher Dose - Enhanced Protocol 75 mg/day 25 mg three times daily

Source: peptide-db.com ↗
Side effects

Common Side Effects

Scalp irritation, dryness, or itching at the application site (often related to the vehicle/solvent rather than RU-58841 itself) Contact dermatitis in sensitive individuals Scalp flaking or peeling

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides